A first-generation pediatric cancer dependency map
Dharia NV, Kugener G, Guenther LM, Malone CF, Durbin AD, Hong AL, Howard TP, Bandopadhayay P, Wechsler CS, Fung I, Warren AC, Dempster JM, Krill-Burger JM, Paolella BR, Moh P, Jha N, Tang A, Mongomery P, Boehm JS, Hahn WC, Roberts CWM, McFarland JM, Tsherniak A, Golub TR, Vazquez F, Stegmaier K. Nat Genet. 2021 Mar 22; doi: 10.1038/s41588-021-00819-w.
Bromodomain and extra-terminal inhibitors. A consensus prioritisation after the Paediatric Strategy Forum for medicinal product development of epigenetic modifiers in children – ACCELERATE
Pearson AD, DuBois SG, Buenger V, Kieran M, Stegmaier K, Bandopadhayay P, Bennett K, Bourdeaut F, Brown PA, Chesler L, Clymer J, Fox E, French CA, Germovsek E, Giles FJ, Bender JG, Hattersley MM, Ludwinski D, Luptakova K, Maris J, McDonough J, Nikolova Z, Smith M, Tsiatis AC, Vibharkar R, Weiner S, Yi JS, Zheng F, Vassal G
Eur J Cancer. 2021 Mar; 146:115-124. doi: 10.1016/j.ejca.2021.01.018. Epub 2021 Feb 16
Outcomes after first relapse of childhood intracranial ependymoma
Tsai JW, Mahoharan N, Alexandrescu S, Zimmerman MA, Scully J, Chordas C, Clymer J, Wright KD, Filbin M, Ullrich NJ, Marcus KJ, Haas-Kogan D, Chi SN, Bandopadhayay P, Yeo KK
Pediatr Blood Cancer. 2021 Feb 9. e28930.doi:10/1002/pbc.28930